Aldosterone is principally synthesized in the zona glomerulosa of the adrenal by a series of enzymatic reactions leading to the conversion of cholesterol to aldosterone. Angiotensin II (Ang II) is the major physiological regulator of aldosterone production acting acutely to stimulate aldosterone biosynthesis and chronically to increase the capacity of the adrenals to produce aldosterone. We previously defined eight transcription factors that are rapidly induced following Ang II treatment using three in vitro adrenocortical cell models. Herein, we investigated the function of these transcription factors in the regulation of the enzymes needed for aldosterone production. H295R adrenal cells were co-transfected with expression vectors for each transcription factor and promoter/reporter constructs prepared for genes encoding the enzymes needed for aldosterone production. NGFI-B family members induced promoter activity of 3-betahydroxysteroid-dehydrogenase type 2 (HSD3B2), 21-hydroxylase (CYP21A2), and aldosterone synthase (CYP11B2). The importance of NGFI-B in the regulation of CYP11B2 was also demonstrated by reduced CYP11B2 transcription in the presence of a dominant-negative-NGFI-B. A pharmacological approach was used to characterize the Ang II pathways regulating transcription of NGFI-B family genes. Transcription of NGFI-B members were decreased following inhibition of Ang II type 1 receptor (AT1R), protein kinase C (PKC), calcium/calmodulin-dependent kinases (CaMK), and Src tyrosine kinase (SRC). Taken together, these results suggest that Ang II binding to the AT1R increases activity of PKC, CaMK, and SRC, which act to increase expression of the family of NGFI-B genes as well as CYP11B2. Ang II induction of the NGFI-B family members represents an important pathway to increase the capacity of adrenal cells to produce aldosterone.
Introduction
Angiotensin II (Ang II) is a major regulator of salt and water balance through regulation of aldosterone synthesis in the zona glomerulosa of the adrenal cortex. Aldosterone biosynthesis is regulated at two steps: 1) an early rate-limiting step that involves the transport of cholesterol into the mitochondria via the action of steroidogenic acute regulatory (StAR) protein and, 2) a late rate-limiting step that involves conversion of corticosterone to aldosterone by the enzyme CYP11B2 (Quinn & Williams 1988 , Muller 1995 . StAR is stimulated by Ang II both in vitro (Tremblay et al. 1992 , Clark et al. 1995 , Cherradi et al. 1997 , Betancourt-Calle et al. 2001 and in vivo (Peters et al. 1998 , Lehoux et al. 1999 . Ang II also stimulates the expression of steroidogenic enzymes in vitro, which are involved in subsequent steps of aldosterone synthesis, including cholesterol side-chain cleavage (SCC or CYP11A1; Bird et al. 1996) , HSD3B2 (Rainey et al. 1991) , and CYP21A2 (Bird et al. 1998 ). Finally, Ang II stimulates the last regulatory step in the control of aldosterone production: the transcription of CYP11B2, an enzyme almost uniquely localized in the zona glomerulosa of the adrenal gland (Shibata et al. 1991 , Adler et al. 1993 .
Adrenal glomerulosa cell stimulation occurs predominantly through Ang II activation of Ang II type 1 receptor (AT1R) via a q-subunit of G-protein coupled receptors (G q ), activation of inositol trisphosphate/ Ca 2C signaling and protein kinase C (PKC) isoforms (Hunyady & Catt 2006) . G-protein stimulation also leads to activation of calcium/calmodulin-dependent kinases (CaMK; Chabre et al. 1995 , Cote et al. 1998 , and mitogen-activated protein kinase (MAPK) members, such as mitogen-activated protein kinase and kinaseextracellular signal-regulated kinase 1 and 2 (MEK-ERK1/2). Ang II can also act through G proteinindependent pathways including b-arrestins, tyrosine kinases, and Janus kinase (JAK)/signal transduction and activators of transcription pathways (Seta et al. 2002 , Thomas & Qian 2003 , Wei et al. 2003 , Miura et al. 2004 . Ang II activation of diverse signaling pathways culminates with rapid induction of adrenal cell transcription for numerous response genes (Romero et al. 2004 , Nogueira et al. 2007 ). Herein, we extend our earlier study that defined the transcription factors regulated by Ang II stimulation in adrenocortical cell models from three different species: human, bovine, and rat (Nogueira et al. 2007 ). The common genes across these three species include eight transcription factors: members of the nuclear receptor superfamily/ nerve growth factor-induced (NGFI-B) family (NGFI-B (also named NR4A1), NURR-1 (also named NR4A2), and NOR-1 (also named NR4A3)), members of the AP-1 complex (FOS, FOSB, and JUNB) , the early growth response gene 1 (EGR1), and the activating transcription factor 3 (ATF3; Nogueira et al. 2007 ). These findings confirm the studies performed by Romero et al. (2004) , who have also studied Ang II responsive genes in H295R cells. In the present study, we examined the role of these transcription factors in the regulation of the enzymes involved in adrenal aldosterone synthesis. In addition, we investigated the Ang II intracellular signaling pathways that control transcription of the NGFI-B genes. We showed that Ang II, through activation of PKC, CaMK, and Src tyrosine kinase (SRC) signaling increased expression of the three members of the NGFI-B transcription factor family which were able to enhance transcription of enzymes needed for the final three steps of the aldosterone biosynthesis pathway.
Materials and methods
Cell culture and treatments H295R human adrenocortical tumor cells were cultured in DME/Ham's F12 medium (Invitrogen) and supplemented with 10% cosmic calf serum (Hyclone, Logan, UT, USA), 1% penicillin/streptomycin (Invitrogen) and 0 . 01% gentamicin (Invitrogen). Cells were maintained in a 37 8C humidified atmosphere (5% CO 2 ). For experiments, cells were subcultured onto 12 well cultured dishes (Corning Costar, Corning, NY, USA) at a density of 4!10 5 cells/well for subsequent transfection.
H295R-TR, an adrenal cell line containing a tetracycline response system, was generously provided by Dr Enzo Lalli (Doghman et al. 2007) . Dominant-negative (DN)-NGFI-B was produced by truncating the 5 0 transactivation region of the human NGFI-B sequence. DN-NGFI-B, lacking 78 to 1099 bp from the full-length NGFI-B cDNA, encoded a variant protein without the transactivation domain. This protein exhibits normal DNA binding capacity without mediating transcriptional activation, thus acting as an inhibitor for all three subfamily members: NGFI-B, NURR-1, and NOR-1. For generation of H295R-TR stably expressing DN-NGFI-B (H295R-TR-DN), cDNA of DN-NGFI-B was amplified by PCR with forward and reverse primers: 5 0 -CACCATGT CAACCAAGGCCCG-3 0 and 5 0 -GAGAGTGCGCATGTG-CACACG-3 0 respectively. The PCR product was ligated into the Invitrogen pLENTI6/V5 TOPO vector (Invitrogen) and packaged into a virus construct using Invitrogen's ViraPower Lentiviral Gateway Expression System (Invitrogen). Briefly, 293T cells were co-transfected with the pLENTI6/V5 TOPO vector with ligated DN-NGFI-B gene and packaging vectors for 6 h using Transfast (Promega) according to manufacturer instructions. Transfection was stopped by adding 2! low serum medium (0 . 2% cosmic calf serumC2% penicillin/streptomycin and 0 . 02% gentamicin).
Twelve hours later the medium was substituted with growth medium for 2 d to allow virus packaging. The medium was then collected for further infection. H295R-TR cells were infected overnight with a 1:2 dilution of virus containing medium harvested from 293T cells and stayed in antibiotic-free growth medium for another 24 h. Further antibiotic selection with 200 mg/ml zeocin (Gemini, West Sacramento, CA, USA) was done for 3 weeks. In this study, we used a mixed population of cells containing a tetracyclineregulated DN-NGFI-B. Doxycycline (tetracycline analog) was used at a concentration of 0 . 25 mg/ml to control the expression of integrated genes. H295R-TR-DN cells were cultured in DME/Ham's F12 medium (Invitrogen) and supplemented with 10% cosmic calf serum (Hyclone), 1% penicillin/streptomycin (Invitrogen), 0 . 01% gentamicin (Invitrogen), 5 mg/ml blasticidin (Invitrogen), 1% insulin-transferrin-selenous acid (BD Biosciences, Bedford, MA, USA). Cells were subcultured onto 24-well culture dishes (Corning Costar) at a density of 2!10 5 cells/well for subsequent treatment. Cells were incubated for 6 h with or without 10 nM Ang II. Twelve hours prior to treatment, the H295-TR cells were maintained overnight in 1! low serum medium (DMEM/F12 medium supplemented with 0 . 1% Cosmic Calf serum medium, 1% penicillin/ streptomycin, and 0 . 01% gentamicin). Experiments were repeated five times.
In order to determine if the transcription factors studied were direct targets of Ang II, H295R cells were pre-treated with 35 mM cycloheximide for 30 min, followed by treatment with 10 nM Ang II for 1 h. RNA was isolated from these cells and used for microarray analysis.
For analysis of Ang II intracellular signaling pathways, H295R cells were sub-cultured onto 24-well dishes at a density of 2!10 5 cells/well. For experiments cells were incubated for 30 min with the following cell signaling inhibitors: 10 mM PD98059 (ERK1/2 inhibitor), 1 mM GFX (or GF103209X -PKC inhibitor), 3 mM KN93 (CAMK inhibitor), SRC-I (SRC inhibitor), and 50 mM AG490 (JAK2 inhibitor), 10 mM losartan (AT1R inhibitor), 10 mM PD123319 (AT2R inhibitor). The inhibitors' concentrations were selected based on screening experiments where three different concentrations were tested on H295R cells. KN93, SRC-I, AG490, and PD98059 were purchased from Calbiochem (Gibbstown, NJ, USA); Losartan (DUP753) was purchased from DuPont Pharmaceutical (Wilmington, DE, USA); PD123319 was purchased from Sigma-Aldrich; and GFX was purchased from Invitrogen. After pre-treatment with inhibitors, cells were treated with 10 nM Ang II for 1 or 6 h.
Microarray analysis
RNA from H295R cells was hybridized to an Affymetrix human HG_U133C2 oligonucleotide microarray set containing 54 675 probe sets representing w40 500 independent human genes. The arrays were scanned at high resolution in the microarray core facility at the Medical College of Georgia in Augusta, GA. Results were analyzed using GeneSpring software version 7.3 (Silicon Genetics, Redwood City, CA, USA) to identify differences in gene expression after incubation with cycloheximide (30 min) followed by Ang II (1 h) compared with cycloheximide (30 min) alone.
Adrenal cell transfection
H295R cells were transfected using Transfast reagent (Promega Corporation) following the manufacturer's protocols. The pGL3-basic (pGL3b) plasmids of 1 mg containing luciferase reporter vectors linked to the promoter region of each of the steroidogenic enzymes involved in aldosterone synthesis, namely: StAR, CYP11A1, CYP21A2, HSD3B2, or CYP11B2, was used for each transfection experiment. The pGL3b vectors were individually co-transfected with 0 . 1 mg of the following transcription factors: ATF3, EGR1, NGFI-B, NURR-1, or NOR-1 in pCMV-XL5; and FOS, FOSB, or JUNB in pcDNA3.1-zeo. All experiments were repeated a minimum of five times.
In addition, H295R cells were co-transfected with combinations of transcription factors. In these experiments, 1 mg of the reporter vectors for the enzymes investigated in our study (StAR, CYP11A1, HSD3B2, CYP21A2, and CYP11B2) was co-transfected with different combinations of expression vectors for the transcription factors using a dose of 0 . 1 mg for each expression vector. In this study, the expression vector for JUNB was co-transfected with the expression vector for FOS, FOSB, or ATF3.
In the DN-NGFI-B and NURR-1 co-transfection study, H295R cells were co-transfected under similar conditions with the following doses: 0 . 1 mg of NURR-1, 0 . 5 mg of DN-NGFI-B vectors, and 1 mg of CYP11B2 reporter vector.
Luciferase-mediated bioluminescence assay
Cell lysate from transfected H295R cells was plated in a 20 ml/well volume followed by immediate addition of 50 ml of the luciferase reagent (Promega Corporation) following the manufacturer's instructions. Microplate was read using the FLUOstar Optima instrument (BMG Labtech, Durham, NC, USA). The empty vector containing pGL3b was used as control to normalize the measurements of luciferase activity.
RNA extraction, cDNA synthesis, and real-time RT-PCR Total RNA was extracted using the RNeasy kit (Qiagen) according to protocols from the manufacturer. Purity and integrity of the RNA were checked spectroscopically using Nanodrop instrument (NanoDrop Technologies, Wilmington, DE, USA). Total RNA was reverse transcribed using the high-capacity cDNA archive kit (Applied Biosystems, Foster City, CA, USA). Primers for the amplification of the target sequences were designed using Primer Express 3.0 (Applied Biosystems). Primer sequences for the transcription factors used in this study are listed in the supplementary data of our previous article (Nogueira et al. 2007 ). The DN-NGFI-B primer sequences were F: 5 0 -CGACCTGCTCTCCG GTTCT-3 0 , R: 5 0 -CAGCAAAGCCAGGGATCTTC-3 0 . PCR amplifications were performed using the ABI 7500 Fast Real-Time PCR System (Applied Biosystems) following the reaction parameters recommended by the manufacturer, using 20 ml total volume consisting of Fast Reagent Master Mix (Applied Biosystems), primers/probes mix, and cDNA. The gene 18S (Applied Biosystems) was used as the normalization gene. Negative controls contained water instead of cDNA.
In all experiments, the relative gene expression was calculated by the C t method. Briefly, the resultant mRNA was normalized to a calibrator; in each case, the calibrator chosen was the basal sample. Final results were expressed as n fold difference in gene expression relative to 18s rRNA and calibrator as follows: n foldZ 2 KðDC t sampleKDC t calibratorÞ , where C t values of the sample and calibrator were determined by subtracting the average C t value of the transcript under investigation from the average C t value of the 18s rRNA gene for each sample.
Aldosterone measurement
Aldosterone content of the medium recovered from each well was determined with aldosterone standards prepared in low-serum medium using aldosterone RIAs (Siemens, Los Angeles, CA, USA). Results of aldosterone essay were normalized to cellular protein and expressed as pmol per mg cell protein.
Statistical analysis
All values were expressed as a meanGS.E.M. One way ANOVA was used to compare groups in the transfection study as well as in the inhibitor study. P values lower than 0 . 05 were considered statistically significant.
Results

Ang II directly induces expression of transcription factors
Inhibition of protein synthesis by pre-incubating H295R cells with cycloheximide (35 mM) allowed us to better define the direct versus indirect Ang II gene targets. In the presence of CX, Ang II (10 nM) treatment for 1 h increased the expression of ATF3, EGR1, FOS, FOSB, JUNB, NGFI-B, NURR-1, and NOR-1 ( Fig. 1 ) as was previously observed in the absence of cycloheximide (Nogueira et al. 2007) . These data suggest that these genes are direct targets of Ang II in H295R cells.
Effects of transcription factors on aldosterone synthesis pathway
AP-1 complex
Members of the AP-1 complex are known to regulate gene transcription as homo-or heterodimers with members of its own family (Mukai et al. 1998 ). In the present study, H295R cells were co-transfected with vectors for each individual member of the AP-1 complex and the reporter vectors for StAR, CYP11A1, HSD3B2, CYP21A2, and CYP11B2. The significance was determined by comparing the promoter activity in the presence of the empty vector, pDNA3.1zeo, to the promoter activity in the presence of the transcription factor. In Fig. 2A and B, we demonstrate that FOS and FOSB caused a reduction of w50% in the promoter activity of CYP21A2. No other significant effects were observed.
Co-transfection of JUNB alone did not significantly change the promoter activity of the enzymes tested in our study. However, the combination of JUNB with FOS caused an approximate twofold increase in StAR and a 65% decrease in CYP21A2 promoter activity. Similar effects were seen with a combination of JUNB with FOSB, which increased the promoter activity of StAR by twofold and decreased the promoter activity of CYP21A2 by 85%. JUNB and FOSB also decreased CYP11B2 reporter activity by 70% ( Fig. 2A and B ).
ATF3 and EGR1
The transfection of H295R cells with expression vector for ATF3 did not significantly change the promoter activity of StAR, CYP11A1, CYP21A2, HSD3B2, or CYP11B2. Because ATF3 is known to heterodimerize Figure 1 Microarray scatter plot for Ang II plus cycloheximide vs cycloheximide alone. Total RNA was isolated from H295R cells that were incubated with 35 mM cycloheximide alone or followed by a combination with 10 nM Ang II for 1 h. Labeled genes represent the transcription factors previously shown to be commonly up-regulated by Ang II treatment in human, bovine, and rat adrenocortical cells (Nogueira et al. 2007) . with JUNB (Nilsson et al. 1997) , we also carried out co-transfection experiments. Interestingly, co-transfection of ATF3 with JUNB significantly increased the promoter activity of StAR and CYP11A1 by 2-and 3-fold respectively (Fig. 3A) .
The role of EGR1 has not been studied for the transcription of adrenal steroidogenic enzymes. Co-transfection of EGR1 with the selected steroidogenic promoters caused a twofold increase in the promoter activity of CYP21A2. However, EGR1 reduced the promoter activity of CYP11B2 by 50% as shown in Fig. 3B . StAR, CYP11A1, and HSD3B2 were not affected.
NGFI-B family
H295R cells respond to Ang II acutely with changes in gene transcription including the induction of all members of the NGFI-B family of nuclear hormone receptors (Bassett et al. 2004a , Romero et al. 2004 , Kelly et al. 2005 , Nogueira et al. 2007 ). In the present study, H295R cells were co-transfected with NGFI-B, NURR-1, or NOR-1 plasmids and luciferase reporter-vectors linked to the promoter region of StAR, CYP11A1, CYP21A2, HSD3B2, or CYP11B2. In agreement with the sequence analysis, NGFI-B significantly increased promoter activity of HSD3B2, CYP21A2, and CYP11B2 by w2-, 3-, and 5-fold respectively (Fig. 4A) ; NURR-1 significantly induced promoter activity of these enzymes by 2-, 3-, and 4-fold respectively (Fig. 4B) ; and NOR-1 significantly increased promoter activity of the same enzymes by 2-, 2-, and 3-fold respectively (Fig. 4C ). An examination of the proximal promoter regions for each of these genes indicated the presence Figure 4 Effects of NGFI-B family members (NGFI-B, NURR-1, NOR-1) on the promoter activity of the genes encoding the enzymes needed for aldosterone synthesis (A, B, and C). H295R cells were co-transfected with each transcription factor (0 . 1 mg/ml) and each of the steroidogenic enzyme promoter/reporter vectors (1 mg/ml). Identification of NGFI-B and SF-1 binding elements in the promoter region of the genes needed for aldosterone synthesis (D). The consensus DNA NGFI-B binding site is distinguished from the SF-1 binding site by 3 bp located 5 0 to the nuclear receptor half-site: A-A-A for NGFI-B and T/A-C/A-A for SF-1. For analysis of significance, comparison was made with the promoter activity in the presence of the control vector (empty vectorZCMV-XL5) shown in gray bars vs promoter activity in the presence of the transcription factor (black bars). Results representGS.E.M. for five independent experiments. P!0 . 05 was considered significant. Angiotensin II response genes . E F NOGUEIRA and others 323 of putative NGFI-B binding cis-elements (AAAGGTCA) in CYP21A2, HSD3B2 and CYP11B2 (Fig. 4D ). The statistical significance was determined by comparing the promoter activity in the presence of empty vector with the promoter activity in the presence of the transcription factor. These results suggest that NGFI-B family members increase aldosterone production by inducing expression of the enzymes involved in the last three steps of aldosterone synthesis: HSD3B2, CYP21A2, and CYP11B2.
Expression of DN-NGFI-B decreased transcription of CYP11B2
The truncation present in the activator function 1 (AF-1) domain of the DN-NGFI-B decreases the function of endogenous NGFI-B members through competition for its NGFI-B regulatory element binding site (NBRE; Cheng et al. 1997 , Song et al. 2001 ). DN-NGFI-B H295-TR cells contain a tetracycline responsive system that induces the transcription of this truncated protein after treatment with doxycycline (tetracycline analog). After incubation with doxycycline for 24 h, cells were treated with 10 nM Ang II for 6 h. As shown in Fig. 5A , DN-NGFI-B mRNA levels were sixfold higher in doxycycline treated cells. This increase in DN-NGFI-B expression was concomitant with a 40% reduction in CYP11B2 mRNA and a 25% reduction in aldosterone levels ( Fig. 5B and C) . Treatment with doxycycline did not affect basal levels of CYP11B2 ( Fig. 5B -gray bars) . In addition, 11b-hydroxylase (CYP11B1) mRNA levels were not modified by DN-NGFI-B expression (data not shown).
We also used the DN-NGFI-B expression vector to study the regulation of CYP11B2 transcription. In Fig. 5D , transfection of H295R cells with NURR-1 expression vector induced a sevenfold increase in the promoter activity of CYP11B2 in comparison to its empty vector (CMV-XL5). However, when NURR-1 was co-transfected with the DN-NGFI-B expression vector, activity of CYP11B2 was reduced by 68% in comparison to control levels (NURR-1Cvector only).
Ang II signaling pathways that regulate NGFI-B family
Ang II activates several intracellular signaling cascades that modulate cellular function. It has been documented that Ang II regulates aldosterone production through AT1R, PKC, CaMK, and SRC signaling pathways (Spat & Hunyady 2004) . Here, we investigated signaling pathways that regulate Ang II induction of NGFI-B family members. Figure 6 shows the mRNA For all panels the results representGS.E.M. for four independent experiments. P!0 . 05 was considered significant. E F NOGUEIRA and others . Angiotensin II response genes Figure 6 Investigation of Ang II-activated signaling pathways that regulate expression of the NGFI-B family members and CYP11B2. H295R cells were pre-treated with inhibitors for 30 min followed by Ang II incubation for 1 h. Transcript levels for NGFI-B, NURR-1, NOR-1 and CYP11B2 were measured using qPCR. LOS (losartanZAT1R inhibitor); PD123319 (AT2R inhibitor), GFX (or GF103209XZ levels for NGFI-B members and CYP11B2 after Ang II-incubation for 1 h in the presence (black bars) or absence (gray bars) of selective inhibitors of Ang II intracellular signaling pathways. As seen in Fig. 6A , inhibition of AT1R signaling by losartan reduced transcription of the three members of NGFI-B family and CYP11B2 to basal levels; whereas PD123319 (AT2R blocker) did not significantly change the expression of these genes. As shown in Fig. 6B , PKC inhibition by GFX reduced the mRNA levels of NGFI-B members by more than 50%. In contrast, this inhibitor caused a small but significant 1 . 25 fold increase in CYP11B2 transcription. Inhibition of CaMK caused a significant reduction of w20% in NGFI-B, 40% in NURR-1 and NOR-1, and 70% in CYP11B2 mRNA levels. Inhibition of SRC signaling with SRC-I was also able to significantly decrease expression of NGFI-B (20%), NURR-1 (50%), NOR-1 (50%), and CYP11B2 (60%). Inhibition of JAK2 signaling (using AG490) and ERK1/2 (using PD98059) did not significantly change expression of CYP11B2 in our study (data not shown). Finally, alterations in aldosterone production were found to correlate well with inhibitor effects on CYP11B2 mRNA expression (data not shown).
Discussion
One of the chronic actions of Ang II is its ability to increase the capacity for aldosterone biosynthesis in the adrenal cortex. This occurs through an increase in the proteins need for aldosterone synthesis including StAR, CYP11A1, HSD3B2, CYP21A2, and CYP11B2. The transcription of these genes is regulated through the activation of signaling cascades that influence the activity of already present transcription factors as well as by increasing expression of new transcription factors. We recently defined a group of transcription factors that are rapidly induced following Ang II treatment of adrenocortical cells. In the current study, we demonstrated that these genes are direct targets of Ang II. In addition, we assessed the function of these factors in the transcriptional control of genes encoding the steroidogenic enzymes needed for aldosterone production ( Fig. 7) .
AP-1 complex transcription factors have been shown to play a role in the trophic effects of Ang II in several tissues including the adrenal cortex (Watanabe et al. 1996 , Suzuki et al. 2003 , Hattori et al. 2007 ). The induction of AP-1 complex members by Ang II in Figure 7 Schematic of Ang II induction of aldosterone production by adrenal glomerulosa cells. Ang II binding to its type 1 receptor (AT1R) activates diverse intracellular signaling pathways, including Src kinase (SRC), protein kinase C (PKC), and calcium-dependent calmodulin kinases (CaMK). This cascade of events induces transcription of rapid response genes such as members of the NGFI-B family, which act as transcription factors for downstream genes including those that are needed for aldosterone synthesis: HSD3B2, CYP21A2, and CYP11B2. These kinases may also phosphorylate and activate several other transcription factors already present in the cell, such as the activator factor 1 and 2 (ATF1, ATF2), and the cAMP-response element binding protein (CREB). Physiologically, Ang II action on the adrenal culminates with increased size and capacity of the zona glomerulosa to produce aldosterone. adrenal cells and their role in adrenal steroidogenesis have also been reported previously (Naville et al. 2001 , Guo et al. 2007 , Romero et al. 2007 . Importantly, members of this family commonly need to homo-and/ or heterodimerize among themselves or with other transcription factors to induce transcription (Mukai et al. 1998 , Guo et al. 2007 ). In the present study, we investigated the effect of FOS, FOSB, and JUNB individually and in combination (FOSCJUNB or FOSBCJUNB) on the promoter activity of selected steroidogenic enzymes. A previous study of these genes using transfection of H295R cells suggested a greater role of the AP-1 members in CYP11B1 (Romero et al. 2007) . This observation is supported by the presence of a putative AP-1 site in the CYP11B1 but not CYP11B2 gene promoter region (Mukai et al. 1995 , Rainey 1999 . In our study, AP-1 members alone had no significant effect on genes needed for aldosterone production with the exception of an inhibition of CYP21A2. However, combination of these vectors (FOSCJUNB and FOSBCJUNB) stimulated the promoter activity of StAR (early regulatory step in aldosterone production). Intriguingly, the combination of FOS and JUNB further decreased the promoter activity of CYP21A2 when compared with the effect of FOS and FOSB alone. In summary, it is important to consider that the ratios of AP-1 complex members may be important in determining the ultimate cellular phenotype and the role of these transcription factors in steroidogenesis.
Although other members of the ATF family, such as ATF1 and ATF2, have been implicated in the regulation of CYP11B2 , Wang et al. 2000 , the effects of ATF3 on the genes needed for aldosterone synthesis have not been described previously. Herein, we investigated the effects of ATF3 alone and in combination with JUNB, since these two transcription factors have been shown to interact (Nilsson et al. 1997) . Interestingly, this combination resulted in a stimulatory effect of the genes needed to complete the early steps of aldosterone synthesis, specifically StAR and CYP11A1. Once again, the ratios of transcription factors stimulated by Ang II are likely to be important in determining the steroidogenic enzyme expression pattern in adrenocortical cells. Further studies will be needed to define the binding sites that are involved in ATF3 regulation of these genes.
EGR1 has been extensively studied with regard to its role in cell growth and proliferation (Cao et al. 1990 , Zhu et al. 2007 . Despite the stimulatory effect of the EGR2 isoform on CYP11B2, Romero et al. (2007) Romero and colleagues reported no effect of EGR1 on CYP11B2 gene. We observed that, although EGR1 stimulated CYP21A2 transcription, it decreased CYP11B2 promoter activity. In other tissues, EGR1 synergizes with SF-1 to stimulate LH expression in gonadotrope cells (Dorn et al. 1999) . SF-1 has been shown to inhibit CYP11B2 expression in adrenocortical cells (Bassett et al. 2002 , Li et al. 2004 , Shibata et al. 2004 , Ye et al. 2008 . Thus, the possibility of interaction between these two proteins may provide a potential mechanism contributing to zonespecific repression of CYP11B2.
Among the eight transcription factors studied, the three members of the NGFI-B family (NGFI-B, NURR-1, and NOR-1) up-regulated the transcription of genes responsible for the last three steps in aldosterone production: HSD3B2, CYP21A2, and CYP11B2. We investigated the presence of NBRE sites in the promoter regions of the enzymes needed for aldosterone synthesis. As shown in Fig. 4D, HSD3B2 , CYP21A2, and CYP11B2 were the only enzymes involved in aldosterone biosynthesis that have consensus NBRE sites in their proximal promoter regions. This fact may explain the ability of the NGFI-B family to selectively stimulate the promoter activity of these genes. The present study confirms previous reports that indicated a role of the NGFI-B family in the regulation of adrenalspecific gene expression in vitro and in vivo (Crawford et al. 1995 , Fernandez et al. 2000 , Bassett et al. 2004a ). Bassett et al. (2004b) have described the binding of NGFI-B and NURR-1 to the NBRE and Ad5 cis-elements present in the 5 0 -flanking region of hCYP11B2. This study further demonstrated the selective effects of these transcription factors on the transcription of HSD3B2 and CYP11B2, whereas no effect was observed on the transcription of CYP11B1 or CYP17. The NGFI-B members have also been reported by Romero et al. (2007) to have a stimulatory effect on CYP11B2 expression in H295R cells. Earlier studies suggested that NGFI-B (Nurr77 in mice) could regulate transcription of mouse CYP21A2 (Wilson et al. 1993 , Chang & Chung 1995 . However, mice deficient in NGFI-B appeared to have similar adrenal responses and expression of CYP21A2 to that seen in wild-type mice (Crawford et al. 1995) . Interpretation of this study is complicated by the possible compensation by other members of the NGFI-B family in mouse adrenocortical function (Crawford et al. 1995) . To address this concern, we used a DN form of NGFI-B that blocks transcriptional activity of all NGFI-B family members (Cheng et al. 1997 , Song et al. 2001 . Expression of DN-NGFI-B in H295R cells decreased the ability of Ang II to maximally stimulate aldosterone production and CYP11B2 transcription. However, DN-NGFI-B did not completely block Ang II stimulation. Partial effects may be due to: 1) the relatively low induction level of DN-NGFI-B (sixfold) compared to w30-fold induction of endogenous NGFI-B members by Ang II or 2) the NGFI-B-independent induction of CYP11B2 transcription, which occurs due to activation of already present CREB and ATF1 (Bassett et al. , 2004c . Thus, the NGFI-B family likely plays an important role in aldosterone production by the adrenals but it is likely that these transcription factors represent only one of several ways that Ang II increases the capacity to produce aldosterone.
The mechanisms through which Ang II regulates the expression of NGFI-B family members have not been well understood. Here, we showed for the first time that Ang II induction of NGFI-B family members occurred uniquely through the AT1R. Similarly, Ang II regulation of CYP11B2 transcription occurred through stimulation of the AT1R in H295R cells. Inhibition of PKC, SRC, as well as calcium signaling through CaMK, was able to partially reduce the expression of NGFI-B members. Inhibition of CaMK also partially blocked the expression of CYP11B2. The role of CaMK in aldosterone synthesis has been previously shown in H295R cells (Pezzi et al. 1997 , Condon et al. 2002 . SRC has been suggested to regulate aldosterone production by stimulation of HSD3B2 and inhibition of 17a-hydroxylase (Sirianni et al. 2001) . Here, we reported for the first time that SRC signaling may regulate aldosterone production through the induction of CYP11B2.
The interpretation of PKC data is complicated by the large number of PKC family members that respond differently to the GFX compound. In addition, adrenal cell activation of different PKC isoforms is known to differentially regulate aldosterone synthesis (LeHoux & Lefebvre 1998 . Interestingly, in our study, inhibition of PKC by GFX caused a small increase in CYP11B2 expression, a result that agrees with those of LeHoux et al. (2001) . This group has also reported that diacylglycerol-regulated PKC can suppress whereas the atypical PKC lambda can enhance the basal expression of CYP11B2 in H295R cells. Thus, the role of PKC isoforms in the regulation of gene expression is likely to be complicated by contrasting actions of different isoforms. Future studies including knockdown of selected PKC isoforms with techniques such as siRNA, may provide important information regarding the role of PKC in aldosterone synthesis.
Using adrenocortical cells, we have shown that large numbers of genes are increased within a short time of Ang II stimulation. Acutely, Ang II increases the expression of hundreds of genes, most of which have not been studied with regard to adrenal function. Our study confirms and extends previous reports related to the role of acutely responsive transcription factors in adrenal steroidogenesis, including the NGFI-B family that appears to increase expression of enzymes involved in aldosterone biosynthesis. In addition, we provide a broad examination of the role of these transcription factors in the transcription of all the genes needed for the synthesis of aldosterone. Based on the current study, Fig. 7 provides a summary of the molecular mechanisms involved in the regulation of aldosterone synthesis. Further studies that focus on the interactions between Ang II responsive transcription factors and those already present will help to better understand the mechanisms controlling the capacity of the adrenal to produce aldosterone.
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